|
Centers for Medicare and Medicare Services (CMS)- NIH Data Access Committee
|
Committee, Work group, Advisory group, or Task Force
|
CMS
|
NINR, CC, CSR, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIMH, NIMHD, NINDS, NLM, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/OSP
|
Observational studies based, in part, on available Centers for Medical and Medicare Services (CMS) data could generate important knowledge and policy relevant findings. NIH and CMS established a Data Access Committee to identify and pursue short and long term research priorities. Current initiatives include: implementation of an Inter-Agency Agreement wherein NIH directly purchases blanket access to CMS data from CMS, instead of paying grantees to access these data individually (which incurs high indirect cost rates for NIH); and convening quarterly meetings of the CMS-NIH Data Access Committee to discuss data policy and access issues. Future meetings may include presentations by NIH-funded investigators and in-house CMS data analyses.
|
|
Characterize Emerging HIV Strains from Blood Donors and Patients
|
Resource Development
|
FDA
|
NIAID
|
This initiative will characterize emerging HIV strains from blood donors and patients to determine viral tropism based on co-receptor usage strains. It will update the global viral panels to analyze multiple, diverse isolates from different parts of the world. This activity is part of NIAID’s ongoing efforts to develop a well-characterized repository for diagnostics, and drug and vaccine studies.
|
|
Chemical Integrated Program Team (IPT)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NICHD
|
This workgroup is a Public Health Energy Enterprise. The Chemical Integrated Program Team (IPT) working group provides an end-to-end vision of medical countermeasures needed for a particular threat type (e.g., anthrax, radiation/nuclear, etc.). The scope of their work includes setting requirements for the stockpiling of Medical Countermeasures (MCMs), MCM delivery, and dispensing and monitoring MCM development. The IPTs also advise the Enterprise Executive Committee as to threat- or capability-specific MCM priorities for improving preparedness, to inform leadership consideration of cross-threat prioritizations and strategic goal setting.
|
|
Chemical, Biologic, Radiologic, Nuclear and Explosive (CBRNE) Branch Subject Matter Advisory Resource Team (SMART)
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NICHD
|
The Subject Matter Advisory Resource Team (SMART) works to conduct analysis of response issues or problems in an unencumbered, academic environment to triage potential issues out or provide decision support when indicated. Participation is generally limited to facilitate rapid analysis and fluid discussion. Depending on the natural of any incident (e.g. Chem, Bio, Nuke/Rad, etc.), this list will be augmented and subject specific participants may be added or subtracted.
|
|
CHEMM (Chemical Hazards Emergency Medical Management)
|
Resource Development
|
ATSDR, CDC, OS
|
NLM, NICHD
|
This activity is to develop and maintain a comprehensive web resource and mobile app (in conjunction with the Wireless Information System for Emergency Responders [WISER]). Chemical Hazards Emergency Medical Management (CHEMM) is a tool designed to provide access to comprehensive sets of information about chemical hazards and emergency medical management via a user-friendly interface.
|
|
Chronic Fatigue Syndrome Advisory Committee (CFSAC)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, OS
|
NINDS, CSR, NCATS, NCCIH, NCI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NICHD, NIDCR, NIDDK, NIEHS, NIMH, NINR, NLM, OD/DPCPSI/OBSSR
|
The Chronic Fatigue Syndrome Advisory Committee (CFSAC) provides advice and recommendations to the Secretary of Health and Human Services via the Assistant Secretary for Health of the U.S. Department of Health and Human Services on issues related to myalgic encephalomyelitis and chronic fatigue syndrome (ME/CFS). These include: 1) factors affecting access and care for persons with ME/CFS; 2) the science and definition of ME/CFS; and 3) broader public health, clinical, research and educational issues related to ME/CFS.
|
|
Clinical and Translational Research Course for PhD Students
|
Training Initiative
|
FDA
|
CC, NCATS, NCI, NHLBI, NIAID, NIDA, NIDCR, NIDDK, NIGMS, NIMH, NINDS
|
The Clinical and Translational Research Course for Ph.D. Students is a two-week intensive introductory course for graduate students in the basic biomedical sciences who have at least one year of graduate study. The purpose of the course is to demonstrate and highlight the roles of PhD scientists in clinical and translational research, to provide an overview and examples of how basic science and clinical observations lead to translational research, and to increase awareness and access to Ph.D. role models, research resources, and potential career opportunities at the NIH.
|
|
Clinical Decision Support (CDS) Federal Collaboratory and Inventory of Federal Clinical Decision Support Activities
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, HRSA, IHS, OS
|
NLM, CC
|
A federal community of interest focused on clinical decision support (CDS), and a compilation of project summaries describing CDS activities that are either funded by the US Federal government, or that are being executed by agencies of the government. CDS encompasses a variety of tools and technologies that are used within electronic clinical information systems to improve the quality, safety, efficiency and effectiveness of patient care. CDS provides clinicians, staff, patients, and other key decision makers with knowledge and person-specific information, intelligently filtered at appropriate times, to enhance health and health care. CDS encompasses computerized alerts and reminders, clinical guidelines, order sets, order entry feedback, patient data reports and dashboards, documentation templates, diagnostic support, and the presentation of contextually relevant reference information within clinical information systems. NLM has submitted to the Collaboratory and Inventory summaries of NLM projects involving Clinical Decision Support.
|
|
Clinical Intervention to Help Pregnant Women Quit Smoking in the US
|
Research Initiative
|
CDC
|
NICHD
|
The purpose of this Interdepartmental Delegations Authority (DDA) activity is to support a study to further understanding of an effective clinical intervention to help pregnant women quit smoking in the US.
|
|
Clinical Investigator Interagency Working Group for the Development of Antiviral Influenza Therapeutics
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
This working group discusses a range of issues relevant to the development of antiviral drugs for the treatment of influenza.
|